Literature DB >> 25921466

Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky.

Yehuda L Danon1, Gerd Sutter2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921466      PMCID: PMC4412943          DOI: 10.1128/CVI.00782-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


× No keyword cloud information.
  3 in total

1.  Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 -- conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2014-01-03

2.  Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.

Authors:  Hiroyuki Yokote; Yasuhiko Shinmura; Tomomi Kanehara; Shinichi Maruno; Masahiko Kuranaga; Hajime Matsui; So Hashizume
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

3.  Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.

Authors:  Asisa Volz; Martin Langenmayer; Sylvia Jany; Ulrich Kalinke; Gerd Sutter
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

  3 in total
  4 in total

1.  Reply to "Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky".

Authors:  Hiroyuki Yokote; Yasuhiko Shinmura
Journal:  Clin Vaccine Immunol       Date:  2015-05

2.  Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant.

Authors:  Sarah Reeman; Amanda J Gates; David J Pulford; Art Krieg; David O Ulaeto
Journal:  Viruses       Date:  2017-12-09       Impact factor: 5.048

Review 3.  Challenges and Achievements in Prevention and Treatment of Smallpox.

Authors:  Sharon Melamed; Tomer Israely; Nir Paran
Journal:  Vaccines (Basel)       Date:  2018-01-29

4.  Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism.

Authors:  Hana Pilna; Vera Hajkova; Jarmila Knitlova; Jana Liskova; Jana Elsterova; Zora Melkova
Journal:  Viruses       Date:  2021-10-03       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.